(Q43800117)

26 November 2017

Nucleolar delocalization of human topoisomerase I in response to topotecan correlates with sumoylation of the protein (English)

1 reference

26 November 2017

1 reference

Yin-Yuan Mo

1

1 reference

26 November 2017

Yanni Yu

series ordinal

2

1 reference

26 November 2017

Zhiyuan Shen

series ordinal

3

1 reference

26 November 2017

William T Beck

series ordinal

4

1 reference

26 November 2017

language of work or name

English

0 references

publication date

14 November 2001

1 reference

Journal of Biological Chemistry

26 November 2017

1 reference

26 November 2017

277

1 reference

26 November 2017

4

1 reference

26 November 2017

2958-2964

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108263200

26 November 2017

1 reference

Tumor cell death induced by topoisomerase-targeting drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108263200

cDNA cloning of human DNA topoisomerase I: catalytic activity of a 67.7-kDa carboxyl-terminal fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108263200

The domain organization of human topoisomerase I

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108263200

A novel nuclear localization signal in human DNA topoisomerase I

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108263200

Structure and Function in the Nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108263200

Cell cycle analysis of amount and distribution of nuclear DNA topoisomerase I as determined by fluorescence digital imaging microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108263200

Alteration of the nucleolar localization of poly(ADP-ribose) polymerase upon treatment with transcription inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108263200

Modification of Ran GTPase-activating protein by the small ubiquitin-related modifier SUMO-1 requires Ubc9, an E2-type ubiquitin-conjugating enzyme homologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108263200

Functional heterogeneity of small ubiquitin-related protein modifiers SUMO-1 versus SUMO-2/3

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108263200

The ubiquitin-like proteins SMT3 and SUMO-1 are conjugated by the UBC9 E2 enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108263200

SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108263200

SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108263200

Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108263200

SUMO-1 modification activates the transcriptional response of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108263200

Sumo-1 modification regulates the DNA binding activity of heat shock transcription factor 2, a promyelocytic leukemia nuclear body associated transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108263200

Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108263200

Cell cycle-regulated attachment of the ubiquitin-related protein SUMO to the yeast septins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108263200

Posttranslational modification of TEL and TEL/AML1 by SUMO-1 and cell-cycle-dependent assembly into nuclear bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108263200

SUMO, ubiquitin's mysterious cousin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108263200

SUMO-1 conjugation to topoisomerase I: A possible repair response to topoisomerase-mediated DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108263200

An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108263200

Association of human DNA topoisomerase IIalpha with mitotic chromosomes in mammalian cells is independent of its catalytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108263200

Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108263200

SUMO-1 conjugation to human DNA topoisomerase II isozymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108263200

The sentrin-conjugating enzyme mUbc9 interacts with GLUT4 and GLUT1 glucose transporters and regulates transporter levels in skeletal muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108263200

A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108263200

Regulation of Pax3 transcriptional activity by SUMO-1-modified PML

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108263200

Regulation of p53 activity in nuclear bodies by a specific PML isoform

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108263200

Daxx, a novel Fas-binding protein that activates JNK and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108263200

Sequestration and inhibition of Daxx-mediated transcriptional repression by PML

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108263200

Identification of a nucleolin binding site in human topoisomerase I

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108263200

Interaction between the N-terminus of human topoisomerase I and SV40 large T antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108263200

Interaction between human topoisomerase I and a novel RING finger/arginine-serine protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108263200

SUMO--nonclassical ubiquitin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108263200

SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108263200

Associations of UBE2I with RAD52, UBL1, p53, and RAD51 proteins in a yeast two-hybrid system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108263200

c-Jun and p53 Activity Is Modulated by SUMO-1 Modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108263200

Functional expression of human DNA topoisomerase I and its subcellular localization in HeLa cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108263200

Ubiquitin-dependent destruction of topoisomerase I is stimulated by the antitumor drug camptothecin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108263200

21 January 2018

Identifiers

DOI

10.1074/JBC.M108263200

1 reference

26 November 2017

1 reference